Date Filed | Type | Description |
03/08/2023 |
4
| OSBORNE DAVID W (Chief Technical Officer) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns:
| Sold 690 shares
@ $15.2634, valued at
$10.5k
|
|
03/06/2023 |
4
| OSBORNE DAVID W (Chief Technical Officer) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns:
| Granted 14,900 shares
@ $0 Granted 39,500 options to buy
@ $15.82, valued at
$624.9k
|
|
03/02/2023 |
4
| OSBORNE DAVID W (Chief Technical Officer) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns:
| Sold 792 shares
@ $16.1663, valued at
$12.8k
Sold 1,198 shares
@ $15.8185, valued at
$19k
Sold 15 shares
@ $16.52, valued at
$247.8 |
|
07/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/21/2022 |
4
| OSBORNE DAVID W (Chief Technical Officer) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns:
| Sold 2,197 shares
@ $20.4243, valued at
$44.9k
|
|
03/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/16/2021 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
12/16/2020 |
4
| OSBORNE DAVID W (Chief Technical Officer) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns:
| Sold 15,000 shares
@ $30, valued at
$450k
|
|
10/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/03/2020 |
4
| OSBORNE DAVID W (Chief Technical Officer) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns:
| Granted 9,000 shares
@ $0 Granted 12,000 options to buy
@ $27.61, valued at
$331.3k
|
|
02/04/2020 |
4
| OSBORNE DAVID W (Chief Technical Officer) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns:
| Converted 24,991 shares
@ $0 Converted 24,991 preferred shares
@ $0 |
|
01/30/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |